Page last updated: 2024-09-03

sch 23982 and antalarmin

sch 23982 has been researched along with antalarmin in 1 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(antalarmin)
Trials
(antalarmin)
Recent Studies (post-2010) (antalarmin)
8700181076

Protein Interaction Comparison

ProteinTaxonomysch 23982 (IC50)antalarmin (IC50)
Corticotropin-releasing factor receptor 1Homo sapiens (human)0.0186

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Card, K; Djouma, E; Lawrence, AJ; Lodge, DJ1

Other Studies

1 other study(ies) available for sch 23982 and antalarmin

ArticleYear
The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.
    The European journal of neuroscience, 2006, Volume: 23, Issue:12

    Topics: Amygdala; Animals; Behavior, Animal; Benzazepines; Brain-Derived Neurotrophic Factor; Dopamine Agonists; Dopamine Antagonists; Male; Nucleus Accumbens; Pyrimidines; Pyrroles; Rats; Rats, Inbred Strains; Receptor, trkB; Receptors, Corticotropin-Releasing Hormone; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Social Isolation; Up-Regulation

2006